glutathione synthetase deficiency schizophrenia in the early postnatal developmental period as a neurodevelopmental animal model of | Pharmacological Reports Cystine/Glutamate Antiporter in Schizophrenia: From
Cystine Glutamate Antiporter in Schizophrenia: From Molecular Mechanism to Novel Biomarker and Treatment Altered serum glutathione disulfide levels in acute relapsed schizophrenia are associated with clinical symptoms and response to electroconvulsive therapy BMC Psychiatry Springer Nature Link Frontiers Fundamental Role of Methylenetetrahydrofolate Reductase 677 C T Genotype and Flavin Compounds in Biochemical Phenotypes for Schizophrenia and Schizoaffective Psychosis From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment Neuropsychopharmacology Impaired glutathione synthesis in schizophrenia: Convergent genetic and functional evidence PNAS
Pay in 4 interest-free payments of $7.12 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11




